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de São Paulo, 14040-903, Ribeirão Preto-SP, Brazil
*Author to whom correspondence should be addressed. Email: psbonato@hotmail.com; isidro.gonzalez@uca.es
Received 12 July 2012; revised 31 August 2012
A high-performance liquid chromatography (HPLC) method is pre-
sented for the simultaneous determination of midodrine and desgly-
midodrine (DMAE) in Czapek-Dox culture medium, to be used in
biotransformation studies by fungi. The HPLC analysis was con-
ducted using a Lichrospher 100 RP18 column, acetonitrile–
40 mmol/L formic acid solution (60:40, v/v) as mobile phase, and
ultraviolet detection at 290 nm. The sample preparation was con-
ducted by liquid– liquid extraction using ethyl acetate as extractor
solvent. The method was linear over the concentration range of 0.4–
40.0 mg/mL for midodrine (r  0.9997) and DMAE (r  0.9998).
Within-day and between-day precision and accuracy were evaluated
by relative standard deviations ( 8.2%) and relative errors (27.3 to
7.4%), respectively. The validated method was used to assess mido-
drine biotransformation by the fungi Papulaspora immersa Hotson
SS13, Botrytis cinerea UCA 992 and Botrytis cinerea 2100 under
static and shaken conditions. Under shaken conditions, the biotrans-
formation of midodrine to DMAE was more efficient for all studied
fungi, especially for the fungus Botrytis cinerea 2100, which con-
verted 42.2% of midodrine to DMAE.
Introduction
Midodrine is a pro-drug of desglymidodrine (DMAE), developed
by the attachment of the amino acid approach glycine to the
functional amine of DMAE (Figure 1). The prodrug midodrine
is primarily converted into its active drug in the liver and in
the systemic circulation by unknown peptidases (1, 2). DMAE
is a long acting a-adrenergic agonist that causes elevation of
systemic blood pressure, accompanied by a reduction in heart
rate (3), and it is therapeutically used for the treatment of
orthostatic hypotension (4). Until now, the metabolism of
midodrine has not been extensively studied (3), and the pro-
duction of DMAE by fungi may be used to provide sufficient
amounts of the metabolite to further be used in pharmaco-
logical, toxicological and analytical tests.
Many researchers have reported the production of drug meta-
bolites using microbial biotransformations (5), and the use of
microorganisms for simulating the mammalian metabolism of
many molecules of pharmacological importance is well docu-
mented (6, 7, 8).
Papulaspora immersa H. H. Hotson (Ascomycetes,
Sordariales, Chaetomiaceae) is a familiar soil competitor mold
in the culture of mushrooms (9), and it has been recently
reported as endophyte in a few plant species such as Vitex
negundo (10), Solanum tuberosum (11), and Smallanthus
sonchifolius (12). Moreover, this fungus has been highlighted
as a producer of phenol-oxidizing and amylase enzymes (13),
and was recently used on the biotransformation of albendazole
(14). Endophytes are a special kind of fungi that inhabit intern-
al plant tissues without causing visible disease symptoms (15).
These fungi are an especially unexplored, or at least under-
explored, source for microbial biotransformation (16).
The fungus Botrytis cinerea is a fungi imperfecti that
belongs to the order Moniliales of the family Moniliaceae. They
are geographically widespread, and are polyphagous parasites
that cause serious economic losses to commercial crops (17).
The biotransformation ability of Botrytis species has been sum-
marized, and the hydroxylase and oxidase activities were the
more frequently observed reactions (18).
To simultaneously determine midodrine and DMAE in bio-
logical matrices (primarily plasma), some methods have been
developed based on radioisotope-labeled techniques (19), high-
performance liquid chromatography (HPLC) with fluorescence
(20, 21, 22) and ultraviolet (UV) detection (23), and capillary
electrophoresis (CE) (24). The HPLC method with fluorescence
detection described by Posch and Lindner (20) is quite compli-
cated because it requires a column-switching technique (20),
and the other HPLC with fluorescence detection methods (21,
22) are not validated. Moreover, the method published by
Quaglia et al. (23) is enantioselective, not applicable to the
intended purpose. More recently, Barth et al. (24) described
another enantioselective method based on a CE method.
Therefore, the aim of the present study was the development
of an HPLC method with UV detection to be used to evaluate
the ability of the fungi Papulaspora immersa and Botrytis




The reference substance, midodrine hydrochloride, was pur-
chased from Sigma-Aldrich (St. Louis, MO), whereas DMAE was
prepared by acidic hydrolysis following the procedure
described by Quaglia et al. (4). In this procedure, a solution of
midodrine hydrochloride (0.001 mol) in 2 mol/L HCl (10 mL)
was refluxed for three hours. After this, the solution was
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cooled, alkalinized with 60% NaOH and extracted by ethyl
acetate. The organic layer was dried over anhydrous Na2SO4, fil-
tered and evaporated under reduced pressure. The crude
extract was purified on C18 Sep-Pak cartridges (Waters, Milford,
MA) using methanol–water (8:2, v/v) plus 0.5% of triethylamine,
as mobile phase. The 1H and 13C nuclear magnetic resonance
(NMR) spectra were used to confirm the structure of DMAE.
Methanol and ethyl acetate were purchased from Carlo Erba
(Val de Reuil, France) and acetonitrile was purchased from
Merck (Darmstadt, Germany), all of chromatographic grade.
Formic acid was purchased from Panreac (Barcelona, Spain). All
other chemicals were of analytical grade in the highest purity
available. Water was purified with a Milli-Q plus system
(Millipore, Bedford, MA).
Reference substance solutions
The midodrine and DMAE stock solutions were prepared at the
concentration of 1 mg/mL. The working solutions of midodrine
and DMAE were 4, 12, 40, 100, 200, 300, and 400 mg/mL. All
were prepared in methanol on a free-base basis. The solutions
were stored frozen at –208C and protected from light.
Liquid chromatographic conditions
The liquid chromatographic analyses were conducted using a
VWR-Hitachi chromatograph (Darmstadt, Germany), equipped
with an L2130 quaternary solvent pump unit and an L2400
UV-Vis detector operating at 290 nm. Injections (25 mL) were
performed automatically through an L2200 auto-injector. An
EZChrom Elite Client/Server software, version 3.1.6, was used for
system control and data acquisition. The analyses of midodrine
and DMAE were performed at room temperature (25+28C) on a
Lichrospher 100 RP18 column (250 4.6 mm i.d, 5 mm particle
size; Merck) using acetonitrile–40 mmol/L formic acid solution
(60:40, v/v) as the mobile phase at the flow rate of 1.4 mL/min.
Extraction procedure
Midodrine and DMAE were extracted from the Czapek-Dox
culture medium (described in Midodrine biotransformation
procedure) by a liquid–liquid extraction (LLE) procedure
adapted from Barth et al. (24). Aliquots of 0.5 mL Czapek-Dox
medium spiked with 50 mL of reference solutions of midodrine
and DMAE or samples obtained in the biotransformation
process were transferred to 10 mL glass tubes and alkalinized
with 50 mL of 10 mol/L sodium hydroxide solution. The
samples were mixed by vortex agitation for 20 s. Then, a 4 mL
aliquot of extraction solvent, ethyl acetate, was added. The
tubes were vortex-mixed for 2 min and then centrifuged at
1,800 g for 10 min. The organic layers (3 mL) were transferred
Figure 2. Representative chromatograms (under conditions described in “Liquid Chromatographic Conditions”; all samples extracted by an LLE procedure): blank Czapek-Dox
culture medium (A); blank Czapek-Dox culture medium spiked with 10 mg/mL of midodrine and DMAE (B). Peaks: midodrine (1); DMAE (2).
Figure 1. Chemical structures of midodrine and DMAE.
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into 10 mL conical glass tubes. The solvent was evaporated to
dryness under a stream of compressed air at room temperature.
The residues were dissolved in 100 mL of mobile phase and
vortex-mixed for 20 s, and then analyzed by HPLC.
Method validation
To determine the extraction recovery, Czapek-Dox medium
samples (0.5 mL) were spiked with midodrine and DMAE at the
concentrations of 1.2, 20.0 and 30.0 mg/mL (n ¼ 3) for each
analyte and submitted to the extraction procedure. Another set
of samples was prepared by extracting 0.5 mL aliquots of
Czapek-Dox medium and then spiking the extract with the
same amounts of midodrine and DMAE. The recovery was deter-
mined by comparing the peak area of solutions submitted and
not submitted to the extraction procedure, and the recovery
was expressed as the percentage of the extracted amount.
Calibration curves were obtained by spiking aliquots of
Czapek-Dox medium with standard solutions of midodrine and
DMAE in the concentration range of 4–400 mg/mL, resulting in
concentrations of 0.4–40 mg/mL for each analyte. The linearity of
the calibration curves was determined using the correlation coef-
ficient (r) and the F-test for lack-of-fit (FLOF) using a p-value of
0.05. The statistical software MINITAB version 14.1 (State College,
PA) was used to perform the statistical calculations.
The sensitivity of the method was evaluated by determining
the limit of quantification (LOQ) (25). The LOQ was defined as
the lowest analyte concentration that could be determined
with accuracy and precision below 20% (25) over five analytical
runs. The LOQ was determined by using Czapek-Dox culture
medium (0.5 mL) spiked with 0.4 mg/mL of each analyte (the
lowest point in the calibration curve).
The precision and accuracy of the method were evaluated by
within-day (n ¼ 5) and between-day (n ¼ 3) assays using
Czapek-Dox medium samples spiked with midodrine and
DMAE in the concentrations of 1.2, 20.0 and 30.0 mg/mL of
each analyte. The results obtained were expressed as relative
standard deviation (RSD, %) and relative error (RE, %).
Freeze-thaw cycle stability, short-term room temperature sta-
bility and stability under biotransformation conditions were
determined. To perform the freeze–thaw cycle stability, three
aliquots (n ¼ 3) of samples, prepared in Czapek-Dox culture
medium at the concentration of 1.2 and 30.0 mg/mL of mido-
drine and DMAE, were stored at –208C for 24 h and thawed at
room temperature. When completely thawed, the samples
were refrozen for 12 h under the same conditions. The freeze–
thaw cycle was repeated two more times, and then the
samples were analyzed after the third cycle. For the determin-
ation of short-term room temperature stability, aliquots of
samples prepared in Czapek-Dox culture medium at the con-
centrations specified previously were kept at room tempera-
ture (22+28C) for 12 h and analyzed.
To determine the stability under static biotransformation con-
ditions, an aliquot of 6 mg of midodrine (on a free-base basis) dis-
solved in 750 mL of sterile water was added to Roux bottles
Table IV
Freeze–Thaw, Short-Term Room Temperature and Autosampler Stability of Midodrine and
Desglymidodrine in Czapek-Dox Medium
Analyte Midodrine DMAE
Fresh sample concentration (mg/mL) 1.26 32.05 1.14 33.22
Stability
Freeze-thaw cycles (n ¼ 3)
Concentration (mg/mL) 1.34 33.59 1.25 33.70
Precision (RSD, %) 2.65 7.70 6.04 6.14
Accuracy (RE, %) 6.49 4.81 9.92 1.44
Short-term (n ¼ 3)
Concentration (mg/mL) 1.35 33.58 1.19 33.92
Precision (RSD, %) 1.22 0.65 2.78 2.88
Accuracy (RE, %) 7.82 4.77 4.60 2.12
Auto-sampler (n ¼ 3)
Concentration (mg/mL) 1.31 33.99 1.12 32.24
Precision (RSD, %) 3.91 0.95 5.00 2.54
Accuracy (RE, %) 4.08 6.07 –1.20 –2.95
Table V
Stability of Midodrine under Biotransformation Conditions
Incubation time (hours) 0 24 48 72 96 120 144 168
Shaken (n ¼ 3)
Concentration (mg/mL) 35.24 34.45 33.18 34.78 33.50 33.78 33.89 32.99
Precision (RSD, %) 5.2 6.3 1.8 10.4 4.9 8.5 9.3 10.4
Accuracy (RE, %) –2.24 –5.85 –1.31 –4.94 –4.14 –3.83 –6.38
Static (n ¼ 3)
Concentration (mg/mL) 37.34 37.90 37.15 36.25 36.40 35.78 35.96 35.73
Precision (RSD, %) 3.4 7.8 9.7 2.4 10.9 4.7 5.9 9.8




Nominal concentration (mg/mL) 1.2 20.0 30.0 1.2 20.0 30.0
Within-day (n ¼ 5)
Concentration (mg/mL) 1.12 20.40 30.98 1.14 19.74 30.05
Precision (RSD, %) 2.4 3.8 3.1 3.6 4.1 2.5
Accuracy (RE, %) –7.3 1.9 3.2 5.0 1.3 0.2
Between-day (n ¼ 3)
Concentration (mg/mL) 1.12 20.33 31.26 1.12 20.14 29.99
Precision (RSD, %) 4.7 6.7 7.6 3.7 6.9 8.2
Accuracy (E, %) –6.9 1.6 4.0 7.4 0.7 0.0
Table I






Linear equation r ANOVA
Lack-of-fit
F-value p-value
Midodrine 82.0 7.2 0.4–40.0 y ¼ 126688x – 17947 0.9997 2.86 0.055
DMAE 83.9 8.6 0.4–40.0 y ¼ 139789x – 16114 0.9998 0.25 0.934
Table II





RE (%) RSD (%)
Midodrine 0.4 0.439 8.9 5.9
DMAE 0.4 0.443 9.7 5.3
*LOQ, n ¼ 5.
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containing 150 mL of Czapek-Dox medium (40 mg/mL), and sub-
mitted to the same conditions used in the biotransformation
procedure (described in Midodrine biotransformation proced-
ure). On the other hand, to evaluate the stability under shaken
biotransformation conditions, an aliquot of 8 mg of midodrine
(on a free-base basis) dissolved in 1,000 mL of sterile water was
added to Erlenmeyer flasks containing 200 mL of Czapek-Dox
medium (40 mg/mL), and submitted to the same conditions used
in the biotransformation procedure (described in Midodrine bio-
transformation procedure). Daily, during the period of biotrans-
formation (seven days), aliquots of 0.5 mL (n ¼ 3) were analyzed.
The stability of the samples placed into the autosampler was
evaluated using three aliquots (n ¼ 3) of samples prepared in
Czapek-Dox culture medium at the concentrations of 1.2 and
30.0 mg/mL of midodrine and DMAE; the samples were
extracted and placed into the autosampler at room tempera-
ture. The samples were analyzed after 12 h.
The samples of the stability studies were compared with
fresh samples at the same concentrations and were considered
stable if the deviations (expressed as RE, %) observed for the
concentrations from the fresh samples were within +15%.
The selectivity of the method was evaluated by analyzing a
sterile Czapek-Dox medium and a sterile Czapek medium
added to fungal mycelium.
Midodrine biotransformation procedure
Fungi
The fungus Papulaspora immersa Hotson (SS13) used in this
experiment was previously isolated as an endophyte from the
plant Smallanthus sonchifolius (26), and is deposited in the
Laboratório de Quı́mica de Micro-organismos—FCFRP/USP
(Brazil). Moreover, two strains of Botrytis cinerea were
employed in this experiment. B. cinerea (UCA 992) was
isolated from grapes from the Domecq vineyard, Jerez de la
Frontera, Cádiz, Spain. This B. cinerea strain is deposited in the
Universidad de Cádiz, Facultad de Ciencias, Mycological
Herbarium Collection (UCA, Spain). The other strain of
B. cinerea (2100) was purchased from the Colección Española
de Cultivos Tipo (CECT), Facultad de Biologı́a, Universidad de
Valencia, Spain, where this strain is deposited.
P. immersa biotransformation procedure
Three discs of 0.5 cm diameter of potato dextrose agar (PDA)
plugs containing the fungal mycelia were aseptically trans-
ferred to 9.0 cm diameter Petri dishes containing PDA medium
and allowed to grow for seven days at 258C. Biotransformation
was performed using a two-stage fermentation protocol (24,
27). In the first stage (pre-culture), three 0.5 cm uniform discs
were cut with a transfer tube and then inoculated in 50 mL
Falcon tubes containing 10 mL of pre-fermentative liquid broth
(10 g glucose, 5 g tryptone soy broth, 3 g yeast extract, and
10 g malt extract, per liter and with pH adjusted to 6.2 with
0.1 mol/L HCl solution). The Falcon tubes were incubated for
four days (96 h) at 258C on a rotatory shaker (Adolph Kühner,
model CH 4127, Birsfelden, Switzerland) operating at 120 rpm.
The second stage (biotransformation) was conducted under
static and shaken conditions. Under shaken conditions, the
resulting mycelium was transferred to 500 mL Erlenmeyer
flasks containing 200 mL of Czapek-Dox medium (50 g
glucose, 1 g yeast extract, 2 g NaNO3, 5 g K2HPO4, 0.5 g
MgSO4.7H2O and 0.01 g FeSO4.7H2O, per liter) adjusted to a
pH range from 6.5 to 7.0 with 0.1 mol/L HCl solution. In se-
quence, 8 mg of midodrine (on a free-base basis) dissolved in
1,000 mL of sterile water was added to the flask. Control flasks
consisted of culture broth (Czapek-Dox) without midodrine
and fungus, sterile broth with midodrine and sterile broth with
endophytic fungal mycelium. Biotransformation experiments
were conducted at 25 8C, with shaking at 120 rpm for 120 h.
Figure 3. Representative chromatograms of Czapek-Dox medium incubated with: the fungi Botrytis cinerea (2100) under shaken conditions (A); Botrytis cinerea (2100) under
static conditions (B); Papulaspora immersa (SS13) under shaken conditions (C); Papulaspora immersa (SS13) under static conditions (D); Botrytis cinerea (UCA 992) under
shaken conditions (E); Botrytis cinerea (UCA 992) under static conditions (F). The chromatographic conditions described in “Liquid Chromatographic Conditions.”
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Under static conditions the resulting mycelium was trans-
ferred into Roux bottles containing 150 mL of Czapek-Dox
medium. Furthermore, 6 mg of midodrine (on a free-base basis)
dissolved in 750 mL of sterile water were added to the flask.
Just as described previously, control bottles were also per-
formed. Biotransformation experiments were conducted at
258C for 120 h.
Daily aliquots of 3 mL, for both conditions, were collected
from the culture flasks, and 0.5 mL were submitted to the
extraction procedure and analyzed by HPLC.
B. cinerea strains biotransformation procedure
The biotransformation was conducted under static and shaken
conditions. Under the shaken condition, a volume equivalent
to 107 spores was transferred into 500 mL Erlenmeyer flasks
containing 200 mL of Czapek-Dox. After two days’ growth, 8 mg
of midodrine (free-base basis) dissolved in 1,000 mL of
sterile water were added to the flask. Biotransformation experi-
ments were conducted at 25 8C, with shaking at 120 rpm
for 168 h.
Under the static condition, a volume equivalent to 107
spores was transferred into Roux bottles containing 150 mL
of Czapek-Dox medium. Subsequently, 6 mg of midodrine
(free-base basis) dissolved in 750 mL of sterile water were
added to the flask. Biotransformation experiments were con-
ducted at 25 8C during 168 h. Daily aliquots of 3 mL, for
both conditions, were collected from the culture flasks, and
0.5 mL were submitted to the extraction procedure and ana-
lyzed by HPLC. As described previously, control flasks were
also performed.
The biotransformation kinetic studies were presented as
concentration versus collecting interval (hours) profiles. The
efficiency of the biotransformation process was calculated (in
percentage) based on the amount of DMAE in the culture
medium and correlating this amount with the initial amount of
midodrine (time 0). Regarding the repeatability of the biotrans-
formation procedure, the experiment was performed in repli-
cate (n ¼ 2).
Results and Discussion
The resolution of midodrine and DMAE was conducted on a
Lichrospher 100 RP18 column under reverse elution mode.
The evaluated mobile phases were prepared using methanol–
water and acetonitrile–water mixtures. Formic acid was added
to these mobile phases to suppress the ionization of the silanol
groups of the silica support, and its interaction with the ana-
lytes, reducing the tails of the peaks of midodrine and DMAE
that are basic compounds (26). The best separation condition
was achieved with a mobile phase consisting of acetonitrile–
40 mmol/L formic acid solution (60:40, v/v), at a flow rate of
1.4 mL/min and with detection at 290 nm. Under these condi-
tions, the separation of the compounds was performed in
10 min with enough resolution (Rs ¼ 1.52) (Figure 2B).
Method validation
The recoveries of midodrine were approximately 82%, while the
DMAE recoveries were approximately of 84%. The RSD (%) for
the recoveries of both analytes were lower than 15% (Table I).
Linear regression analyses were performed by plotting
the peaks areas of the analytes (y) versus theoretical analyte
concentrations (x). The method proved to be linear over the
concentration range of 0.4–40 mg/mL for both midodrine and
DMAE, with correlation coefficient r  0.9997. The linearity of
the method was also confirmed by the FLOF test (Table I).
The LOQ using the validated method was 0.4 mg/mL for
each analyte. The RSD (%) and RE (%) were lower than 20%
(Table II).
The precision and accuracy of the method were evaluated by
within and between-day assays. The RSDs and relative errors
were lower than 15% (Table III).
The freeze–thaw, short-term room temperature and auto-
sampler stability of midodrine and DMAE in Czapek-Dox
medium showed RSDs and relative errors lower than 15%.
These results are presented in Table IV. Midodrine was stable
for 168 h under the biotransformation conditions (shaken and
Figure 4. Graphs of concentration time-profiles of midodrine and DMAE in culture
medium incubated with: Papulaspora immersa Hotson (A); Botrytis cinerea UCA 992
(B); Botrytis cinerea 2100 (C) under static and shaken conditions. The black circles
represent midodrine under shaken conditions; white circles represent DMAE under
shaken conditions; black squares represent midodrine under static conditions; white
squares represent DMAE under static condition .The bars denote the error of two
replicates.
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static) (RSD and RE , 15%), and no degradation of midodrine
could be observed during this period (Table V).
The studied fungi did not produce any secondary metabolite
that presented retention times close to those of midodrine and
DMAE (Figure 3).
Biotransformation of midodrine
The midodrine biotransformation was evaluated with three
fungi under static and shaken conditions. These different con-
ditions were tested to evaluate the effect of aeration of the cul-
tures and the growth morphology of these fungi. Under static
conditions, a weak oxygenation was observed, and under
shaken conditions this oxygenation was higher (29). Moreover,
under static conditions, the fungi, in general, grew on the
culture surface, while under shaken conditions, spherical
aggregates called pellets are formed (30).
The biotransformation was monitored for 168 h for the
B. cinerea strains and 120 h for the fungus P. immersa. The
concentrations of the analytes were determined based on cali-
bration curves constructed daily. The identification of DMAE
was performed by comparing its retention time with that of
the reference substance.
The endophytic fungus P. immersa Hotson was able to bio-
transform midodrine in the human active metabolite DMAE
(Figure 1). The maximum amount of DMAE was detected in
the extracts of the endophytic fungus culture medium after
Figure 5. Representative chromatogram of Czapek-Dox medium incubated with the fungus Papulaspora immersa Hotson (SS13) and midodrine after 120 h of biotransformation
under static conditions (A); representative chromatogram of Czapek-Dox medium incubated with the fungus Botrytis cinerea 2100 and midodrine after 48 h of biotransformation under
static conditions (B). The chromatographic conditions described in “Liquid Chromatographic Conditions.” Peaks: midodrine (1); DMAE (2); unidentified compounds (3, 4 and 5).
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120 h of midodrine incubation for both conditions. A slightly
higher efficiency (7.9%) under shaken conditions could be
observed than under static conditions (7.3%) (Figure 4A). In
addition, under static conditions, an additional peak was
detected, which can be considered another possible metabolite
of midodrine (peak 3, Figure 5A).
The fungus B. cinerea has extensively been used to biotrans-
form synthetic (31, 32, 33, 34, 35) and natural products (36,
37) with potential fungistatic and fungicide activities. The con-
version of midodrine to DMAE involves an amide hydrolysis re-
action, which has already been observed for B. cinerea (38).
The strain B. cinerea UCA 992 showed better biotransforma-
tion results under shaken conditions. The maximal formation of
DMAE under static conditions (11.5%) was verified in 168 h of
biotransformation (Figure 4B), whereas, under shaken conditions,
a higher concentration of DMAE (29.2%) was observed within
96 h of incubation (Figure 4B). Additional peaks at both biotrans-
formation conditions were not observed for B. cinerea UCA 992.
B. cinerea 2100 showed higher DMAE formation under
shaken conditions (Figure 4C). The maximal amount of formed
DMAE under shaken conditions was verified in 48 h of incuba-
tion (42.2% of biotransformation). On the other hand, under
static conditions, the maximum amount of DMAE was observed
in 72 h of incubation (8.9% of biotransformation). Moreover,
under static conditions, after 48 h of incubation, three addition-
al peaks were observed. These peaks can also be considered
possible midodrine metabolites (peaks 4, 5 and 6, Figure 5B).
The unidentified metabolites (peaks 3, Figure 5A; peaks 4, 5
and 6, Figure 5B) were not studied here. The biotransformation
under static conditions of midodrine by P. immersa Hotson
and B. cinerea 2100 deserve more studies for the isolation and
characterization of these unknown metabolites.
Conclusions
An HPLC–UV method was described for the simultaneous de-
termination of midodrine and DMAE in Czapek-Dox culture
medium. The validation parameters were evaluated and met the
literature requirements (25). This work presents a simpler
method than that published by Posch and Lindner (1989),
which uses fluorescence detection and column-switching pro-
cedures. This method was successfully employed to study mido-
drine biotransformation by the endophytic fungus P. immersa
Hotson and by the phytopatogen strains B. cinerea 2100 and B.
cinerea UCA 992. The biotransformations were conducted
under static and shaken conditions. For all studied fungi, the
shaken conditions resulted in higher DMAE formation, especial-
ly for the fungus B. cinerea 2100, which biotranformed 42.2%
of midodrine to DMAE.
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